US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Medicenna Therapeutics Corp.

0.6600

+0.02604.10%

Volume:208.08K

Turnover:136.87K

Market Cap:55.05M

PE:-5.71

High:0.6750

Open:0.6310

Low:0.6200

Close:0.6340

52wk High:1.43

52wk Low:0.5460

Shares:83.41M

Float Shares:56.07M

Volume Ratio:2.90

T/O Rate:0.37%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1157

EPS(LYR):-0.1147

ROE:-109.77%

ROA:-61.57%

PB:12.13

PE(LYR):-5.75

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Medicenna Therapeutics Corp.

Exchange:

OTCQX

Establishment Date:

- -

Employees:

18

Office Location:

2 Bloor Street West,Suite 903,7th Floor,Toronto,Ontario,Canada

Website:

http://www.medicenna.com

Zip Code:

M4W 3E2

Phone:

Fax:

- -

Introduction:

Medicenna Therapeutics Corp., a clinical stage immunotherapy company, develops and commercializes Empowered Cytokines (EC) and Superkines for the treatment of cancer. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that is in the Phase 2b clinical trial for the treatment of recurrent glioblastoma, as well as preclinical and clinical development stages for the treatment of other brain and non-brain tumors. The company also develops MDNA57 for solid tumors and non-malignant cells of the tumor micro-environment; MDNA109, an IL-2 agonist to treat cancer immunotherapies; MDNA209, an IL-2 antagonist for autoimmune diseases; MDNA413, a dual IL-4/IL-13 antagonist for the treatment of solid tumors, atopic dermatitis, asthma, and fibrosis; and MDNA132, an IL-13 agonist to treat solid tumors and IL 13Ralpha2 chimeric antigen receptor T cell. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MDNAF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MDNAF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDNAF\",,,,,undefined,":{"symbol":"MDNAF","market":"US","secType":"STK","nameCN":"Medicenna Therapeutics Corp.","latestPrice":0.66,"timestamp":1771621200000,"preClose":0.634,"halted":0,"volume":208075,"delay":15,"changeRate":0.04100946372239751,"floatShares":56072225,"shares":83411435,"eps":-0.11568,"marketStatus":"Market Closed","change":0.026,"latestTime":"02-20 16:00:00 EST Delay","open":0.631,"high":0.675,"low":0.62,"amount":136873.595,"amplitude":0.086751,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.11568,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"OTCQX","adjPreClose":0.634,"volumeRatio":2.8984568446093535},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDNAF\",,,,,undefined,":{"symbol":"MDNAF","floatShares":56072225,"roa":"-61.57%","roe":"-109.77%","lyrEps":-0.114717,"volumeRatio":2.8984568446093535,"shares":83411435,"dividePrice":0,"high":0.675,"amplitude":0.086751,"preClose":0.634,"low":0.62,"week52Low":0.54603,"pbRate":"12.13","week52High":1.43,"institutionHeld":0,"latestPrice":0.66,"eps":-0.11568,"divideRate":0,"volume":208075,"delay":15,"ttmEps":-0.11568,"open":0.631,"prevYearClose":0.6762,"prevWeekClose":0.6067,"prevMonthClose":0.6351,"prevQuarterClose":0.6762,"fiveDayClose":0.5562,"twentyDayClose":0.7,"sixtyDayClose":0.98},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDNAF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-07-31","symbol":"MDNAF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722398400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-06-27","symbol":"MDNAF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1719460800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-02-14","symbol":"MDNAF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1707886800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2020-08-24","symbol":"MDNAF","reason":null,"defaultRemindTime":1598275800000,"announcedDate":"2020-08-20","type":"delisting","dateTimestamp":1598241600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDNAF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDNAF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1759208400000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":245978917,"employeeNum":18,"address":"2 Bloor Street West,Suite 903,7th Floor,Toronto,Ontario,Canada","zipCode":"M4W 3E2","officePhone":"416 648 5555"},"stockCompanyDetail":{"websiteUrl":"http://www.medicenna.com","stockEarnings":[{"period":"1week","weight":-0.0379},{"period":"1month","weight":0.2853},{"period":"3month","weight":-0.2138},{"period":"6month","weight":0.4819},{"period":"1year","weight":-0.0905},{"period":"ytd","weight":0.7903}],"description":"Medicenna Therapeutics Corp., a clinical stage immunotherapy company, develops and commercializes Empowered Cytokines (EC) and Superkines for the treatment of cancer. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that is in the Phase 2b clinical trial for the treatment of recurrent glioblastoma, as well as preclinical and clinical development stages for the treatment of other brain and non-brain tumors. The company also develops MDNA57 for solid tumors and non-malignant cells of the tumor micro-environment; MDNA109, an IL-2 agonist to treat cancer immunotherapies; MDNA209, an IL-2 antagonist for autoimmune diseases; MDNA413, a dual IL-4/IL-13 antagonist for the treatment of solid tumors, atopic dermatitis, asthma, and fibrosis; and MDNA132, an IL-13 agonist to treat solid tumors and IL 13Ralpha2 chimeric antigen receptor T cell. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.","exchange":"OTCQX","name":"Medicenna Therapeutics Corp.","nameEN":"Medicenna Therapeutics Corp."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MDNAF\",market:\"US\",,,undefined,":null}}